The 12th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), 22 - 24 February 2022, vol.1, no.68, pp.152
Background: Cutaneous Leishmaniasis is a disease caused by leishmania-type protozoans, which is transmitted by the bite of infected phlebotomine sandflies and is characterized by ulcerated nodular lesions. Aims: Eighteen pediatric cutaneous leishmania cases followed by pediatric infectious diseases and dermatology were included in the study. The demographic and clinical characteristics of the patients, the local or systemic treatments, and side effects were analyzed retrospectively.
Methods: Eighteen pediatric cutaneous leishmania cases followed by pediatric infectious diseases and dermatology were included in the study. The demographic and clinical characteristics of the patients, treatments were analyzed retrospectively. Results: Eleven (60%) of the patients were female and 7 (40%) were male. The mean age of the cases was 6.3 years. Twelve of the patients were refugees (seven were from Iraq, five were Syria). Nine of the patients ( 50%) had lesions on the face, 5 (27%) were both face and hand, 4 (23%) were on the lower extremities. Seven patients (38%) had a single lesion, 11 had multiple lesions. Amastigote was observed in the microbiological examination of skin scraping samples of 11 patients. Intralesional therapy was given to 11 patients, systemic treatment was given to 3 patients, 2 patients refused systemic treatment. No side effects were observed in the follow-up.
Conclusions: Leishmaniasis is a chronic disease caused by flagellate protozoa especially in endemic
countries. CL has become a relatively common condition in all over the world due to international
travel, migration and refugees. Cutaneous leishmania should be considered when there are chronic,
painless skin lesions outside of endemic areas.